Literature DB >> 28315695

An unusual primary malignant tumor of the stomach: fetal gutlike gastric adenocarcinoma with "blastoma"-like component.

Altaf Taher1, Nebojsa Denic1, Sangeetha N Kalimuthu2, Runjan Chetty3.   

Abstract

An unusual case of a polypoid, malignant gastric tumor in a 62-year-old man is presented. Endoscopy and subsequent polypectomy revealed an 8.5 × 6.5 × 4.5-cm lesion in the body of the stomach. Microscopy showed surface dysplasia with an invasive adenocarcinoma displaying prominent tubulopapillary areas composed of large vacuolated cells, pleomorphic nuclei, and occasional cytoplasmic hyaline globules. This component then blended with tubular structures lined by more primitive-appearing vacuolated cells embedded within a stroma made up of cellular primitive, high-grade blastemalike areas and less cellular, more pleomorphic foci with spindle and several bizarre, large cells. Immunohistochemistry showed the adenocarcinoma and primitive tubules to be strongly SALL4 and epithelial marker positive but with only focal expression of α-fetoprotein and glypican-3. The stromal component made up of blastemalike areas displayed strong immunoreactivity for glypican-3. The pleomorphic stromal areas were negative for all markers, including epithelial and muscle markers. The overall morphology and expression of primitive oncofetal proteins, especially SALL4 and glypican-3, are in keeping with this being a primitive adenocarcinoma showing fetal gutlike differentiation with an accompanying blastomalike component, a combination not previously described in a primary gastric cancer.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blastemalike; Gastric cancer; Glypican-3; Primitive tubules; SALL4; Stem cells

Mesh:

Substances:

Year:  2017        PMID: 28315695     DOI: 10.1016/j.humpath.2017.02.023

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  2 in total

Review 1.  Drug-Loaded Microbubbles Combined with Ultrasound for Thrombolysis and Malignant Tumor Therapy.

Authors:  Qian Gong; Xingxing Gao; Wenfang Liu; Tingting Hong; Chuanpin Chen
Journal:  Biomed Res Int       Date:  2019-10-01       Impact factor: 3.411

2.  Hepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular features.

Authors:  Yakun Wang; Li Sun; Zhongwu Li; Jing Gao; Sai Ge; Cheng Zhang; Jiajia Yuan; Xicheng Wang; Jian Li; Zhihao Lu; Jifang Gong; Ming Lu; Jun Zhou; Zhi Peng; Lin Shen; Xiaotian Zhang
Journal:  Gastric Cancer       Date:  2019-04-15       Impact factor: 7.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.